Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

This study has been terminated.
(The study has been stopped for logistic reasons not related to the safety or efficacy of the vaccine.)
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: February 19, 2009
Last updated: October 19, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)